25 XP   0   0   10

Gan & Lee Pharmaceuticals Co Ltd
Buy, Hold or Sell?

Let's analyse Gan & Lee Pharmaceuticals Co Ltd together

PenkeI guess you are interested in Gan & Lee Pharmaceuticals Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gan & Lee Pharmaceuticals Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Gan & Lee Pharmaceuticals Co Ltd

I send you an email if I find something interesting about Gan & Lee Pharmaceuticals Co Ltd.

Quick analysis of Gan & Lee Pharmaceuticals Co Ltd (30 sec.)










What can you expect buying and holding a share of Gan & Lee Pharmaceuticals Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.16
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥16.13
Expected worth in 1 year
¥12.22
How sure are you?
83.3%

+ What do you gain per year?

Total Gains per Share
¥-2.78
Return On Investment
-5.7%

For what price can you sell your share?

Current Price per Share
¥48.78
Expected price per share
¥32.10 - ¥62.90
How sure are you?
50%

1. Valuation of Gan & Lee Pharmaceuticals Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥48.78

Intrinsic Value Per Share

¥-28.26 - ¥-15.29

Total Value Per Share

¥-12.12 - ¥0.84

2. Growth of Gan & Lee Pharmaceuticals Co Ltd (5 min.)




Is Gan & Lee Pharmaceuticals Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.3b$1.4b-$80.3m-6.1%

How much money is Gan & Lee Pharmaceuticals Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$60.6m$200.6m-$261.3m-430.5%
Net Profit Margin-25.7%40.2%--

How much money comes from the company's main activities?

3. Financial Health of Gan & Lee Pharmaceuticals Co Ltd (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#40 / 169

Most Revenue
#56 / 169

Most Profit
#166 / 169

Most Efficient
#127 / 169

What can you expect buying and holding a share of Gan & Lee Pharmaceuticals Co Ltd? (5 min.)

Welcome investor! Gan & Lee Pharmaceuticals Co Ltd's management wants to use your money to grow the business. In return you get a share of Gan & Lee Pharmaceuticals Co Ltd.

What can you expect buying and holding a share of Gan & Lee Pharmaceuticals Co Ltd?

First you should know what it really means to hold a share of Gan & Lee Pharmaceuticals Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Gan & Lee Pharmaceuticals Co Ltd is ¥48.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gan & Lee Pharmaceuticals Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gan & Lee Pharmaceuticals Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥16.13. Based on the TTM, the Book Value Change Per Share is ¥-0.98 per quarter. Based on the YOY, the Book Value Change Per Share is ¥2.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.28 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gan & Lee Pharmaceuticals Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.10-0.2%-0.10-0.2%0.340.7%0.200.4%0.210.4%
Usd Book Value Change Per Share-0.14-0.3%-0.14-0.3%0.290.6%0.290.6%0.370.8%
Usd Dividend Per Share0.040.1%0.040.1%0.050.1%0.050.1%0.050.1%
Usd Total Gains Per Share-0.10-0.2%-0.10-0.2%0.340.7%0.340.7%0.420.9%
Usd Price Per Share4.50-4.50-9.71-6.49-5.41-
Price to Earnings Ratio-44.04--44.04-28.77-9.71-8.09-
Price-to-Total Gains Ratio-46.87--46.87-28.76-1.10-1.10-
Price to Book Ratio2.02-2.02-4.11-2.98-2.49-
Price-to-Total Gains Ratio-46.87--46.87-28.76-1.10-1.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.736518
Number of shares148
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.05
Usd Book Value Change Per Share-0.140.29
Usd Total Gains Per Share-0.100.34
Gains per Quarter (148 shares)-14.2149.84
Gains per Year (148 shares)-56.83199.38
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
123-80-6727172189
246-160-12455344388
370-240-18182516587
493-320-238109688786
5116-400-295137860985
6139-480-35216410321184
7162-560-40919212041383
8185-640-46621913761582
9209-720-52324615481781
10232-800-58027417201980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%

Fundamentals of Gan & Lee Pharmaceuticals Co Ltd

About Gan & Lee Pharmaceuticals Co Ltd

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company's products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection. It also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-18 11:13:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Gan & Lee Pharmaceuticals Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gan & Lee Pharmaceuticals Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Gan & Lee Pharmaceuticals Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -25.7% means that ¥-0.26 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is -25.7%. The company is making a huge loss. -2
  • The TTM is -25.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-25.7%TTM-25.7%0.0%
TTM-25.7%YOY40.2%-65.9%
TTM-25.7%5Y26.1%-51.8%
5Y26.1%10Y29.4%-3.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.7%6.2%-31.9%
TTM-25.7%6.4%-32.1%
YOY40.2%8.0%+32.2%
5Y26.1%7.3%+18.8%
10Y29.4%6.8%+22.6%
1.1.2. Return on Assets

Shows how efficient Gan & Lee Pharmaceuticals Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gan & Lee Pharmaceuticals Co Ltd to the Medical Instruments & Supplies industry mean.
  • -4.1% Return on Assets means that Gan & Lee Pharmaceuticals Co Ltd generated ¥-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is -4.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-4.1%0.0%
TTM-4.1%YOY13.4%-17.5%
TTM-4.1%5Y12.3%-16.4%
5Y12.3%10Y15.0%-2.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.1%1.3%-5.4%
TTM-4.1%1.4%-5.5%
YOY13.4%1.9%+11.5%
5Y12.3%2.1%+10.2%
10Y15.0%2.0%+13.0%
1.1.3. Return on Equity

Shows how efficient Gan & Lee Pharmaceuticals Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gan & Lee Pharmaceuticals Co Ltd to the Medical Instruments & Supplies industry mean.
  • -4.6% Return on Equity means Gan & Lee Pharmaceuticals Co Ltd generated ¥-0.05 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is -4.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.6%TTM-4.6%0.0%
TTM-4.6%YOY14.3%-18.9%
TTM-4.6%5Y13.3%-17.9%
5Y13.3%10Y16.5%-3.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.6%2.6%-7.2%
TTM-4.6%2.8%-7.4%
YOY14.3%3.7%+10.6%
5Y13.3%3.9%+9.4%
10Y16.5%3.9%+12.6%

1.2. Operating Efficiency of Gan & Lee Pharmaceuticals Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gan & Lee Pharmaceuticals Co Ltd is operating .

  • Measures how much profit Gan & Lee Pharmaceuticals Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gan & Lee Pharmaceuticals Co Ltd to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -39.5% means the company generated ¥-0.39  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is -39.5%. The company is operating very inefficient. -2
  • The TTM is -39.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-39.5%TTM-39.5%0.0%
TTM-39.5%YOY38.5%-78.0%
TTM-39.5%5Y26.5%-66.0%
5Y26.5%10Y30.9%-4.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.5%7.9%-47.4%
TTM-39.5%7.6%-47.1%
YOY38.5%10.9%+27.6%
5Y26.5%10.1%+16.4%
10Y30.9%10.5%+20.4%
1.2.2. Operating Ratio

Measures how efficient Gan & Lee Pharmaceuticals Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.57 means that the operating costs are ¥1.57 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is 1.567. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.567. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.567TTM1.5670.000
TTM1.567YOY0.706+0.861
TTM1.5675Y0.832+0.735
5Y0.83210Y0.785+0.046
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5671.152+0.415
TTM1.5671.146+0.421
YOY0.7061.082-0.376
5Y0.8321.097-0.265
10Y0.7851.056-0.271

1.3. Liquidity of Gan & Lee Pharmaceuticals Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gan & Lee Pharmaceuticals Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 6.97 means the company has ¥6.97 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is 6.967. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.967. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.967TTM6.9670.000
TTM6.967YOY14.150-7.184
TTM6.9675Y9.869-2.902
5Y9.86910Y9.202+0.667
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9672.310+4.657
TTM6.9672.339+4.628
YOY14.1502.575+11.575
5Y9.8692.627+7.242
10Y9.2022.623+6.579
1.3.2. Quick Ratio

Measures if Gan & Lee Pharmaceuticals Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gan & Lee Pharmaceuticals Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 2.23 means the company can pay off ¥2.23 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is 2.229. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.229. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.229TTM2.2290.000
TTM2.229YOY5.268-3.040
TTM2.2295Y3.596-1.367
5Y3.59610Y3.238+0.358
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2291.105+1.124
TTM2.2291.137+1.092
YOY5.2681.306+3.962
5Y3.5961.430+2.166
10Y3.2381.533+1.705

1.4. Solvency of Gan & Lee Pharmaceuticals Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gan & Lee Pharmaceuticals Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gan & Lee Pharmaceuticals Co Ltd to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.10 means that Gan & Lee Pharmaceuticals Co Ltd assets are financed with 9.6% credit (debt) and the remaining percentage (100% - 9.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is 0.096. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.096. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.096TTM0.0960.000
TTM0.096YOY0.063+0.033
TTM0.0965Y0.080+0.016
5Y0.08010Y0.085-0.005
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0960.357-0.261
TTM0.0960.360-0.264
YOY0.0630.358-0.295
5Y0.0800.365-0.285
10Y0.0850.375-0.290
1.4.2. Debt to Equity Ratio

Measures if Gan & Lee Pharmaceuticals Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gan & Lee Pharmaceuticals Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 10.7% means that company has ¥0.11 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The MRQ is 0.107. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.107. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.107TTM0.1070.000
TTM0.107YOY0.067+0.039
TTM0.1075Y0.088+0.019
5Y0.08810Y0.093-0.006
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1070.541-0.434
TTM0.1070.561-0.454
YOY0.0670.561-0.494
5Y0.0880.648-0.560
10Y0.0930.669-0.576

2. Market Valuation of Gan & Lee Pharmaceuticals Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Gan & Lee Pharmaceuticals Co Ltd generates.

  • Above 15 is considered overpriced but always compare Gan & Lee Pharmaceuticals Co Ltd to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -44.04 means the investor is paying ¥-44.04 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The EOD is -65.943. Based on the earnings, the company is expensive. -2
  • The MRQ is -44.043. Based on the earnings, the company is expensive. -2
  • The TTM is -44.043. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-65.943MRQ-44.043-21.900
MRQ-44.043TTM-44.0430.000
TTM-44.043YOY28.768-72.812
TTM-44.0435Y9.712-53.755
5Y9.71210Y8.093+1.619
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-65.94314.579-80.522
MRQ-44.04316.584-60.627
TTM-44.04317.443-61.486
YOY28.76822.147+6.621
5Y9.71220.830-11.118
10Y8.09325.069-16.976
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The EOD is -42.203. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -28.187. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -28.187. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-42.203MRQ-28.187-14.016
MRQ-28.187TTM-28.1870.000
TTM-28.187YOY108.247-136.434
TTM-28.1875Y39.847-68.034
5Y39.84710Y33.206+6.641
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-42.2039.822-52.025
MRQ-28.18710.068-38.255
TTM-28.1871.387-29.574
YOY108.2473.453+104.794
5Y39.8475.897+33.950
10Y33.206-0.177+33.383
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gan & Lee Pharmaceuticals Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.02 means the investor is paying ¥2.02 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Gan & Lee Pharmaceuticals Co Ltd:

  • The EOD is 3.024. Based on the equity, the company is fair priced.
  • The MRQ is 2.019. Based on the equity, the company is underpriced. +1
  • The TTM is 2.019. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.024MRQ2.019+1.004
MRQ2.019TTM2.0190.000
TTM2.019YOY4.111-2.091
TTM2.0195Y2.984-0.964
5Y2.98410Y2.487+0.497
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD3.0242.398+0.626
MRQ2.0192.753-0.734
TTM2.0192.690-0.671
YOY4.1113.294+0.817
5Y2.9843.563-0.579
10Y2.4874.227-1.740
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Gan & Lee Pharmaceuticals Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.979-0.9790%2.068-147%2.104-147%2.689-136%
Book Value Per Share--16.13316.1330%17.112-6%12.937+25%11.716+38%
Current Ratio--6.9676.9670%14.150-51%9.869-29%9.202-24%
Debt To Asset Ratio--0.0960.0960%0.063+52%0.080+20%0.085+13%
Debt To Equity Ratio--0.1070.1070%0.067+58%0.088+21%0.093+14%
Dividend Per Share--0.2840.2840%0.378-25%0.335-15%0.335-15%
Eps---0.740-0.7400%2.445-130%1.463-151%1.522-149%
Free Cash Flow Per Share---1.156-1.1560%0.650-278%0.340-440%0.429-369%
Free Cash Flow To Equity Per Share---1.326-1.3260%0.265-601%2.492-153%2.213-160%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---15.291--------
Intrinsic Value_10Y_min---28.257--------
Intrinsic Value_1Y_max---0.064--------
Intrinsic Value_1Y_min---0.569--------
Intrinsic Value_3Y_max---1.311--------
Intrinsic Value_3Y_min---3.680--------
Intrinsic Value_5Y_max---3.907--------
Intrinsic Value_5Y_min---8.925--------
Market Cap28983221579.520+33%19357797438.72019357797438.7200%41793353954.560-54%27942249783.552-31%23285208152.960-17%
Net Profit Margin---0.257-0.2570%0.402-164%0.261-198%0.294-187%
Operating Margin---0.395-0.3950%0.385-203%0.265-249%0.309-228%
Operating Ratio--1.5671.5670%0.706+122%0.832+88%0.785+99%
Pb Ratio3.024+33%2.0192.0190%4.111-51%2.984-32%2.487-19%
Pe Ratio-65.943-50%-44.043-44.0430%28.768-253%9.712-554%8.093-644%
Price Per Share48.780+33%32.58032.5800%70.340-54%47.028-31%39.190-17%
Price To Free Cash Flow Ratio-42.203-50%-28.187-28.1870%108.247-126%39.847-171%33.206-185%
Price To Total Gains Ratio-70.170-50%-46.867-46.8670%28.756-263%1.102-4353%1.102-4353%
Quick Ratio--2.2292.2290%5.268-58%3.596-38%3.238-31%
Return On Assets---0.041-0.0410%0.134-131%0.123-134%0.150-128%
Return On Equity---0.046-0.0460%0.143-132%0.133-134%0.165-128%
Total Gains Per Share---0.695-0.6950%2.446-128%2.439-129%3.024-123%
Usd Book Value--1323776833.4371323776833.4370%1404082365.749-6%1061509366.024+25%961359939.606+38%
Usd Book Value Change Per Share---0.135-0.1350%0.286-147%0.291-147%0.371-136%
Usd Book Value Per Share--2.2282.2280%2.363-6%1.787+25%1.618+38%
Usd Dividend Per Share--0.0390.0390%0.052-25%0.046-15%0.046-15%
Usd Eps---0.102-0.1020%0.338-130%0.202-151%0.210-149%
Usd Free Cash Flow---94841907.068-94841907.0680%53319492.755-278%27907928.983-440%35192478.420-369%
Usd Free Cash Flow Per Share---0.160-0.1600%0.090-278%0.047-440%0.059-369%
Usd Free Cash Flow To Equity Per Share---0.183-0.1830%0.037-601%0.344-153%0.306-160%
Usd Market Cap4002582900.132+33%2673311826.2872673311826.2870%5771662181.125-54%3858824695.109-31%3215687245.924-17%
Usd Price Per Share6.737+33%4.4994.4990%9.714-54%6.495-31%5.412-17%
Usd Profit---60697208.968-60697208.9680%200625446.482-130%120014296.688-151%124868953.912-149%
Usd Revenue--236464555.615236464555.6150%498823252.630-53%385813969.669-39%376073328.113-37%
Usd Total Gains Per Share---0.096-0.0960%0.338-128%0.337-129%0.418-123%
 EOD+5 -3MRQTTM+0 -0YOY+4 -315Y+7 -2810Y+7 -28

3.2. Fundamental Score

Let's check the fundamental score of Gan & Lee Pharmaceuticals Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-65.943
Price to Book Ratio (EOD)Between0-13.024
Net Profit Margin (MRQ)Greater than0-0.257
Operating Margin (MRQ)Greater than0-0.395
Quick Ratio (MRQ)Greater than12.229
Current Ratio (MRQ)Greater than16.967
Debt to Asset Ratio (MRQ)Less than10.096
Debt to Equity Ratio (MRQ)Less than10.107
Return on Equity (MRQ)Greater than0.15-0.046
Return on Assets (MRQ)Greater than0.05-0.041
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Gan & Lee Pharmaceuticals Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.005
Ma 20Greater thanMa 5043.505
Ma 50Greater thanMa 10042.324
Ma 100Greater thanMa 20045.635
OpenGreater thanClose49.580
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Income before Tax  1,113,523283,9461,397,46948,0011,445,470250,5421,696,013-2,278,486-582,473
Net Income  933,965233,3161,167,28163,4301,230,711222,0441,452,755-1,892,271-439,516
EBIT  1,087,672241,4551,329,12685,7011,414,827-24,6021,390,225-2,066,491-676,266
EBITDA  1,214,222259,3971,473,619115,7351,589,354292,5001,881,854-2,263,206-381,352
Operating Income  1,123,048234,7391,357,78771,9711,429,75829,8051,459,564-2,023,838-564,275
Tax Provision  179,55850,631230,189-15,429214,76028,498243,258-386,214-142,957
Income Tax Expense  179,55850,631230,189-15,429214,76028,498243,258-386,214-142,957
Net Income from Continuing Operations  933,965233,3161,167,28163,4301,230,711222,0441,452,755-1,892,271-439,516
Net Income Applicable to Common Shares  933,965233,3161,167,28163,4301,230,711222,0441,452,755-1,892,271-439,516



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets10,606,912
Total Liabilities1,021,273
Total Stockholder Equity9,585,802
 As reported
Total Liabilities 1,021,273
Total Stockholder Equity+ 9,585,802
Total Assets = 10,606,912

Assets

Total Assets10,606,912
Total Current Assets5,664,136
Long-term Assets4,942,776
Total Current Assets
Cash And Cash Equivalents 2,890,267
Short-term Investments 1,635,950
Net Receivables 176,251
Inventory 648,646
Other Current Assets 97,362
Total Current Assets  (as reported)5,664,136
Total Current Assets  (calculated)5,448,476
+/- 215,661
Long-term Assets
Property Plant Equipment 3,661,337
Intangible Assets 1,026,043
Long-term Assets Other 76,513
Long-term Assets  (as reported)4,942,776
Long-term Assets  (calculated)4,763,893
+/- 178,883

Liabilities & Shareholders' Equity

Total Current Liabilities813,037
Long-term Liabilities208,236
Total Stockholder Equity9,585,802
Total Current Liabilities
Accounts payable 41,456
Other Current Liabilities 575,899
Total Current Liabilities  (as reported)813,037
Total Current Liabilities  (calculated)617,355
+/- 195,682
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt8,327
Other Liabilities 199,909
Long-term Liabilities  (as reported)208,236
Long-term Liabilities  (calculated)208,236
+/- 0
Total Stockholder Equity
Common Stock565,653
Retained Earnings 6,525,068
Other Stockholders Equity 3,442
Total Stockholder Equity (as reported)9,585,802
Total Stockholder Equity (calculated)7,094,164
+/- 2,491,638
Other
Capital Stock565,653
Common Stock Shares Outstanding 565,653
Net Invested Capital 9,585,802
Net Tangible Assets 9,292,321
Net Working Capital 4,851,099
Property Plant and Equipment Gross 3,661,337



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
0
3,743,355
4,694,880
6,026,681
9,507,449
10,853,163
10,606,912
10,606,91210,853,1639,507,4496,026,6814,694,8803,743,3550
   > Total Current Assets 
1,314,640
1,970,275
2,444,090
3,110,098
5,959,614
6,870,443
5,664,136
5,664,1366,870,4435,959,6143,110,0982,444,0901,970,2751,314,640
       Cash And Cash Equivalents 
0
817,314
593,530
483,217
2,824,812
3,305,708
2,890,267
2,890,2673,305,7082,824,812483,217593,530817,3140
       Short-term Investments 
0
0
0
1,058,272
787,050
1,624,183
1,635,950
1,635,9501,624,183787,0501,058,272000
       Net Receivables 
392,998
485,915
841,608
852,206
827,077
933,817
176,251
176,251933,817827,077852,206841,608485,915392,998
       Inventory 
145,975
212,319
389,133
471,349
493,482
651,329
648,646
648,646651,329493,482471,349389,133212,319145,975
       Other Current Assets 
15,634
19,227
35,119
43,434
76,583
77,945
97,362
97,36277,94576,58343,43435,11919,22715,634
   > Long-term Assets 
0
1,773,080
2,250,790
2,916,583
3,547,835
3,982,720
4,942,776
4,942,7763,982,7203,547,8352,916,5832,250,7901,773,0800
       Property Plant Equipment 
971,921
1,391,310
1,637,279
1,890,302
2,149,002
2,595,370
3,661,337
3,661,3372,595,3702,149,0021,890,3021,637,2791,391,310971,921
       Intangible Assets 
0
214,486
422,841
591,334
769,623
872,485
1,026,043
1,026,043872,485769,623591,334422,841214,4860
       Long-term Assets Other 
0
156,198
187,221
419,579
600,713
240,326
76,513
76,513240,326600,713419,579187,221156,1980
> Total Liabilities 
0
407,998
424,184
555,883
569,091
686,021
1,021,273
1,021,273686,021569,091555,883424,184407,9980
   > Total Current Liabilities 
271,478
335,811
354,303
458,221
409,850
485,531
813,037
813,037485,531409,850458,221354,303335,811271,478
       Accounts payable 
36,771
12,536
35,287
19,108
14,794
37,741
41,456
41,45637,74114,79419,10835,28712,53636,771
       Other Current Liabilities 
152,043
247,832
191,677
329,081
274,151
281,274
575,899
575,899281,274274,151329,081191,677247,832152,043
   > Long-term Liabilities 
0
72,186
69,881
97,662
159,241
200,490
208,236
208,236200,490159,24197,66269,88172,1860
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
16,125
12,166
8,327
8,32712,16616,1250000
       Long-term Liabilities Other 
0
0
82
683
0
0
0
0006838200
       Deferred Long Term Liability 
29,189
76,865
286,491
474,853
544,275
588,873
743,195
743,195588,873544,275474,853286,49176,86529,189
> Total Stockholder Equity
0
3,335,519
4,270,859
5,470,960
8,938,520
10,167,305
9,585,802
9,585,80210,167,3058,938,5205,470,9604,270,8593,335,5190
   Common Stock
335,000
360,900
360,900
360,900
561,540
561,540
565,653
565,653561,540561,540360,900360,900360,900335,000
   Retained Earnings Total Equity0000000
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
548
114
1,489
2,184
-1,551
-3,440
3,442
3,442-3,440-1,5512,1841,489114548



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,381,052
Cost of Revenue-616,234
Gross Profit1,764,8181,764,818
 
Operating Income (+$)
Gross Profit1,764,818
Operating Expense-2,321,567
Operating Income59,485-556,749
 
Operating Expense (+$)
Research Development539,212
Selling General Administrative1,006,774
Selling And Marketing Expenses-
Operating Expense2,321,5671,545,985
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-93,360
Net Interest Income93,360
 
Pretax Income (+$)
Operating Income59,485
Net Interest Income93,360
Other Non-Operating Income Expenses-
Income Before Tax (EBT)161,45359,485
EBIT - interestExpense = 0
240,765
240,765
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-161,453
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax161,453
Tax Provision--79,312
Net Income From Continuing Ops240,765240,765
Net Income240,765
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--93,360
 

Technical Analysis of Gan & Lee Pharmaceuticals Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gan & Lee Pharmaceuticals Co Ltd. The general trend of Gan & Lee Pharmaceuticals Co Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gan & Lee Pharmaceuticals Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gan & Lee Pharmaceuticals Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 50.31 < 54.00 < 62.90.

The bearish price targets are: 47.50 > 39.12 > 32.10.

Tweet this
Gan & Lee Pharmaceuticals Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gan & Lee Pharmaceuticals Co Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gan & Lee Pharmaceuticals Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gan & Lee Pharmaceuticals Co Ltd. The current macd is 0.96869697.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gan & Lee Pharmaceuticals Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Gan & Lee Pharmaceuticals Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Gan & Lee Pharmaceuticals Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Gan & Lee Pharmaceuticals Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGan & Lee Pharmaceuticals Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gan & Lee Pharmaceuticals Co Ltd. The current adx is 21.32.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Gan & Lee Pharmaceuticals Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Gan & Lee Pharmaceuticals Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gan & Lee Pharmaceuticals Co Ltd. The current sar is 41.29.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Gan & Lee Pharmaceuticals Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gan & Lee Pharmaceuticals Co Ltd. The current rsi is 67.00. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Gan & Lee Pharmaceuticals Co Ltd Daily Relative Strength Index (RSI) ChartGan & Lee Pharmaceuticals Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gan & Lee Pharmaceuticals Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gan & Lee Pharmaceuticals Co Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Gan & Lee Pharmaceuticals Co Ltd Daily Stochastic Oscillator ChartGan & Lee Pharmaceuticals Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gan & Lee Pharmaceuticals Co Ltd. The current cci is 207.94.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Gan & Lee Pharmaceuticals Co Ltd Daily Commodity Channel Index (CCI) ChartGan & Lee Pharmaceuticals Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gan & Lee Pharmaceuticals Co Ltd. The current cmo is 44.99.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Gan & Lee Pharmaceuticals Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGan & Lee Pharmaceuticals Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gan & Lee Pharmaceuticals Co Ltd. The current willr is -12.39766082.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Gan & Lee Pharmaceuticals Co Ltd Daily Williams %R ChartGan & Lee Pharmaceuticals Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gan & Lee Pharmaceuticals Co Ltd.

Gan & Lee Pharmaceuticals Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gan & Lee Pharmaceuticals Co Ltd. The current atr is 2.01829573.

Gan & Lee Pharmaceuticals Co Ltd Daily Average True Range (ATR) ChartGan & Lee Pharmaceuticals Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gan & Lee Pharmaceuticals Co Ltd. The current obv is 140,003,398.

Gan & Lee Pharmaceuticals Co Ltd Daily On-Balance Volume (OBV) ChartGan & Lee Pharmaceuticals Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gan & Lee Pharmaceuticals Co Ltd. The current mfi is 48.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Gan & Lee Pharmaceuticals Co Ltd Daily Money Flow Index (MFI) ChartGan & Lee Pharmaceuticals Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gan & Lee Pharmaceuticals Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Gan & Lee Pharmaceuticals Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gan & Lee Pharmaceuticals Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.005
Ma 20Greater thanMa 5043.505
Ma 50Greater thanMa 10042.324
Ma 100Greater thanMa 20045.635
OpenGreater thanClose49.580
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gan & Lee Pharmaceuticals Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Gan & Lee Pharmaceuticals Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gan & Lee Pharmaceuticals Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gan & Lee Pharmaceuticals Co Ltd

I send you an email if I find something interesting about Gan & Lee Pharmaceuticals Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Gan & Lee Pharmaceuticals Co Ltd.

Receive notifications about Gan & Lee Pharmaceuticals Co Ltd in your mailbox!